The type I insulin-like growth factor receptor pathway: a key player in cancer therapeutic resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The type I insulin-like growth factor receptor pathway: a key player in cancer therapeutic resistance

Published:2008 Issue:13 Volume:Volume Page:3273
ISSN:1093-9946
Container-title:Frontiers in Bioscience
language:en
Short-container-title:Front Biosci

Author:

Casa Angelo, J.

Publisher

IMR Press

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Newly synthesized chitosan nanoparticles loaded with caffeine/moringa leaf extracts Halt Her2, BRCA1, and BRCA2 expressions;Scientific Reports;2024-08-05

2. Tools for investigating O-GlcNAc in signaling and other fundamental biological pathways;Journal of Biological Chemistry;2024-02

3. BEX1 mediates sorafenib resistance in hepatocellular carcinoma by regulating AKT signaling;Cellular Signalling;2023-08

4. Preclinical evaluation of Insulin-like growth factor receptor 1 (IGF1R) and Insulin Receptor (IR) as a therapeutic targets in triple negative breast cancer;PLOS ONE;2023-03-15

5. Circular RNA circ_0001459 accelerates hepatocellular carcinoma progression via the miR‐6165/IGF1R axis;Annals of the New York Academy of Sciences;2022-02-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP